Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-03-05
Metadata
Show full item recordAbstract
As pharmacokinetic modifiers, cell penetrating peptides (CPPs) have proven utility for the delivery of otherwise impermeable cargoes into the discrete intracellular compartments of eukaryotic cells. Methods for the molecular optimisation of CPP sequences can significantly increase the performance of novel vectors matched to a specific delivery function. Moreover, the ‘information rich’ composition and inherent molecular flexibility of many CPPs can also facilitate their interaction with intracellular proteins and other cellular structures. This proteomimetic property of CPPs has been exploited in the design of bioportides, bioactive CPPs that regulate cellular functions often by binding relatively flat PPI interfaces to achieve a dominant negative action. This new biology of CPPs is rapidly gathering momentum through the design and synthesis of a bewildering variety of peptides that may be, in whole or part, linear, helical, cyclic and/or chimeric in nature. A particular emphasis of contemporary CPP‐centred drug discovery is the unmet medical need of cancer, though the biomedical scope of bioportide applications is impressively broad including cellular signalling and reprogramming. We are hopeful that one or more of the fascinating studies described herein will translate into the clinic to establish bioportide technologies as a viable option for drug discovery.Citation
Howl, J. and Jones, S. (2020) A new biology of cell penetrating peptides, Peptide Science. https://doi.org/10.1002/pep2.24154Publisher
WileyJournal
Peptide ScienceAdditional Links
https://onlinelibrary.wiley.com/doi/abs/10.1002/pep2.24154Type
Journal articleLanguage
enDescription
This is an accepted manuscript of an article published by Wiley in Peptide Science on 05/03/2020, available online: https://doi.org/10.1002/pep2.24154 The accepted version of the publication may differ from the final published version.ISSN
2475-8817EISSN
2475-8817Sponsors
British Council; Fundação para a Ciência e a Tecnologia; Michael J. Fox Foundation for Parkinson's Research.ae974a485f413a2113503eed53cd6c53
10.1002/pep2.24154
Scopus Count
Collections
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/